Activities per year
- 8 results
Search results
-
DSP Biomolecules in Health and Disease Symposium July 01-02, 2024
Sieberer, H. (Speaker)
1 Jul 2024 → 2 Jul 2024Activity: Talk or presentation › Oral presentation › science to science / art to art
-
The NLRP3 inhibitor CP-456773 reduces AML cell survival in vitro by downregulation of the FLT3 pathway
Sieberer, H. (Speaker), Luciano, M. (Speaker), Blöchl, C. (Speaker), Krenn, P. (Speaker), Eglseer, A. (Speaker), Unger, M. S. (Speaker), Vetter, J. (Speaker), Andosch, A. (Speaker), Maeding, N. (Speaker), Strunk, D. (Speaker), Greil, R. (Speaker), Huber, C. (Speaker), Aberger, F. (Speaker) & Horejs-Höck, J. (Speaker)
19 Sept 2023 → 21 Sept 2023Activity: Talk or presentation › Oral presentation › science to science / art to art
-
The NLRP3/eIF2 axis promotes leukemic blasts survival and disease progression in acute myeloid leukemia
Unger, M. S. (Speaker), Luciano, M. (Speaker), Sieberer, H. (Speaker), Blöchl, C. (Speaker), Krenn, P. (Speaker), Vetter, J. (Speaker), Andosch, A. (Speaker), Neureiter, D. (Speaker), Strunk, D. (Speaker), Pleyer, L. (Speaker), Greil, R. (Speaker), Huber, C. (Speaker), Aberger, F. (Speaker) & Horejs-Höck, J. (Speaker)
19 Sept 2023 → 21 Sept 2023Activity: Talk or presentation › Oral presentation › science to science / art to art
-
The NLRP3/eIF2 axis in acute myeloid leukemia
Sieberer, H. (Speaker), Unger, M. S. (Speaker), Luciano, M. (Speaker), Krenn, P. (Speaker), Blöchl, C. (Speaker), Vetter, J. (Speaker), Neuper, T. (Speaker), Bauer, R. (Speaker), Dang, H.-H. (Speaker), Greil, R. (Speaker), Huber, C. (Speaker), Aberger, F. (Speaker) & Horejs-Höck, J. (Speaker)
14 Sept 2023 → 16 Sept 2023Activity: Talk or presentation › Oral presentation › science to science / art to art
-
The NLRP3/eIF2 axis in acute myeloid leukemia
Sieberer, H. (Speaker), Unger, M. S. (Speaker), Luciano, M. (Speaker), Krenn, P. (Speaker), Blöchl, C. (Speaker), Vetter, J. (Speaker), Neuper, T. (Speaker), Bauer, R. (Speaker), Dang, H.-H. (Speaker), Greil, R. (Speaker), Huber, C. (Speaker), Aberger, F. (Speaker) & Horejs-Höck, J. (Speaker)
31 May 2023 → 2 Jun 2023Activity: Talk or presentation › Oral presentation › science to science / art to art
-
The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells
Unger, M. S. (Speaker), Urwanisch, L. (Speaker), Sieberer, H. (Speaker), Dang, H.-H. (Speaker), Neuper, T. (Speaker), Regl, C. (Speaker), Vetter, J. (Speaker), Schaller, S. (Speaker), Winkler, S. M. (Speaker), Kerschbamer, E. (Speaker), Weichenberger, C. (Speaker), Krenn, P. (Speaker), Luciano, M. (Speaker), Pleyer, L. (Speaker), Greil, R. (Speaker), Huber, C. (Speaker), Aberger, F. (Speaker) & Horejs-Höck, J. (Speaker)
4 May 2023Activity: Talk or presentation › Poster presentation › science to science / art to art
-
Pharmacological inhibition of NLRP3 in MOLM-13 cells induces hallmarks of cell cycle arrest and apoptosis
Andosch, A. (Speaker), Luciano, M. (Speaker), Sieberer, H. (Speaker), Vetter, J. (Speaker), Tesanovic, S. (Speaker), Aberger, F. (Speaker), Horejs-Höck, J. (Speaker) & Steiner, P. (Speaker)
13 Apr 2023 → 14 Apr 2023Activity: Talk or presentation › Poster presentation › science to science / art to art
-
The role of eIF2 signaling in NLRP3-driven acute myeloid leukemia (AML)
Luciano, M. (Speaker), Blöchl, C. (Speaker), Krenn, P. (Speaker), Sieberer, H. (Speaker), Dang, H.-H. (Speaker), Vetter, J. (Speaker), Neuper, T. (Speaker), Elmer, D. P. (Speaker), Bauer, R. (Speaker), Andosch, A. (Speaker), Steiner, P. (Speaker), Strandt, H. (Speaker), Neureiter, D. (Speaker), Urwanisch, L. (Speaker), Tesanovic, S. (Speaker), Rieser, S. (Speaker), Bergsleitner, O. (Speaker), Zell, L. (Speaker), Binder, S. (Speaker), Schaller, S. (Speaker), Strunk, D. (Speaker), Pleyer, L. (Speaker), Greil, R. (Speaker), Winkler, S. (Speaker), Hartmann, T. N. (Speaker), Huber, C. (Speaker), Aberger, F. (Speaker) & Horejs-Höck, J. (Speaker)
6 Jul 2022 → 9 Jul 2022Activity: Talk or presentation › Oral presentation › science to science / art to art